Via Falloppio, 61 - PADOVA
+39.049.8751435
+39.351.9617779
8.30-12.30 / 15.00-19.00
Sabato pomeriggio chiuso
LIBRERIA STUDIUM
Libreria medica internazionale
- PADOVA -
LIBRERIA STUDIUM
0,00 €
Hypertension
Black, Elliott
Editore
Elsevier
Anno
2013
Pagine
464
ISBN
9781437727661
132,00 €
I prezzi indicati possono subire variazioni poiché soggetti all'oscillazione dei cambi delle valute e/o agli aggiornamenti effettuati dagli Editori.
Description
Clinical hypertension is one of the most serious long-term problems associated with heart disease. This companion to BRAUNWALD'S HEART DISEASE focuses in depth on this key area of cardiovascular medicine. Complete with practical clinical tools for management, it helps you manage the chronic problems of your hypertensive patients. It covers everything from epidemiology and pathophysiology through diagnosis, risk stratification, treatment, outcome studies, concomitant diseases, special populations and special situations, and future treatments.
New to this edition

 

 

  • Use new combination drug therapies and other forms of treatment to their greatest advantage in the management of chronic complications of hypertension.
  • Successfully employ behavior management as a vital part of the treatment plan for hypertensives and pre-hypertensives.
  • Access the complete contents online and download images at www.expertconsult.com.
Author Info
By Henry R. Black, MD, Associate Vice President for Research, Charles J. and Margaret Roberts Professor; Chairman, Department of Preventive Medicine, Rush University Medical Center, Chicago, IL, USA and William Elliott, MD, PhD, Professor, Department of Preventive Medicine, Rush University Medical Center. Chicago, IL, USA

 

Table of Contents:
 

SECTION I: EPIDEMIOLOGY AND PATHOPHYSIOLOGY

1 Epidemiology of Hypertension

2 Pathogenesis of Hypertension

SECTION II: DIAGNOSIS

3 Defining Hypertension

4 Office Blood Pressure Measurement

5 Home Monitoring of Blood Pressure

6 Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management

7 White Coat and Masked Hypertension

8 Secondary Hypertension: Renovascular Hypertension

9 Secondary Hypertension: Renin-Independent Mineralocorticoid Excess States

10 Secondary Hypertension: Pheochromocytoma

11 Secondary Hypertension: Sleep Apnea

12 Rare and Unusual Forms of Hypertension

SECTION III: RISK STRATIFICATION

13 The Natural History of Untreated Hypertension

14 The Special Problem of Isolated Systolic Hypertension 

15 Assessment of Hypertensive Target Organ Damage

16 Prediction of Global Cardiovascular Risk in Hypertension

SECTION IV: TREATMENT

17 Diet and Blood Pressure

18 Diuretic Therapy in Cardiovascular Disease

19 ß-Blockers in Hypertension

20 Angiotensin-Converting Enzyme Inhibitors

21 Angiotensin Receptor Blockers

22 Calcium Channel Blockers in Hypertension

23 a-Blockers

24 New Drugs for Hypertension

25 Devices for Hypertension

SECTION V: OUTCOME STUDIES

26 Design of Outcomes Studies

27 Meta-Analyses of Hypertension Trials: The Blood Pressure Lowering Treatment Trialists’ Collaboration

SECTION VI: HYPERTENSION AND CONCOMITANT DISEASES

28 Ischemic Heart Disease in Hypertension

29 Heart Failure in Hypertension

30 Kidney Disease in Hypertension

31 Transplant Hypertension

32 Obesity in Hypertension

33 Peripheral Artery Disease in Hypertension

34 Cerebrovascular Disease in Hypertension

35 Hypertension and Diabetes Mellitus: An Update

36 Dyslipidemia in Hypertension

SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS

37 Hypertension in Pregnancy

38 Hypertension in Children and Adolescents

39 Hypertension in Older Patients

40 Hypertension in African Americans 

41 Hypertension in Hispanics

42 Hypertension in East Asians and Native Hawaiians

43 Hypertension in South Asians

44 Resistant Hypertension

45 Hypertension and the Perioperative Period

46 Hypertensive Emergencies and Urgencies

SECTION VIII: HYPERTENSION TREATMENT IN THE FUTURE

47 Team-Based Care for the Management of Hypertension

48 Outcomes Research in Hypertension 

49 Pharmacogenetics of Antihypertensive Treatment

50 Antihypertensive Drug Development: A Regulatory Perspective

SECTION IX: GUIDELINES

51 U.S. and Canadian Hypertension Guidelines

52 European and British Guidelines on Hypertension

Informazioni

Non ci sono recensioni

Dettaglio
Aggiungi la tua recensione

Ultimi prodotti